Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
EJNMMI Reports
|
October 30, 2025
Feasibility of different lymph node metastases delineation approaches in [<sup>18</sup>F]SiTATE PET/CT imaging in NET patients
Sophie Carina Siegmund, Magdalena Schöll, Vera U Wenter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic setting
Maximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas
Ricarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
Clinical Nuclear Medicine
|
February 1, 2023
High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Ralph A Bundschuh, Susanne Lütje, Lena Bundschuh, et al.
Cancers
|
July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
Feyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Cancers
|
June 13, 2025
Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma
Sophie Carina Kunte, Adrien Holzgreve, Marcus Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma
Emil Novruzov, Eduards Mamlins, Liam Widjaja, et al.
EJNMMI Research
|
August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Victoria Fusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy
Felix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
EJNMMI Reports
|
October 30, 2025
Feasibility of different lymph node metastases delineation approaches in [<sup>18</sup>F]SiTATE PET/CT imaging in NET patients
Sophie Carina Siegmund, Magdalena Schöll, Vera U Wenter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic setting
Maximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 11, 2025
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas
Ricarda Ebner, Jana Braach, Johannes Rübenthaler, et al.
Clinical Nuclear Medicine
|
February 1, 2023
High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Ralph A Bundschuh, Susanne Lütje, Lena Bundschuh, et al.
Cancers
|
July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic Target
Feyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Cancers
|
June 13, 2025
Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma
Sophie Carina Kunte, Adrien Holzgreve, Marcus Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2026
Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma
Emil Novruzov, Eduards Mamlins, Liam Widjaja, et al.
EJNMMI Research
|
August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
Felix L Herr, Christian Dascalescu, Victoria Fusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy
Felix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
Page
of 6